Angiodynamics Inc (ANGO) Stock Price, Quote & News

Company Profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy sy...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 518 795 1400

Website: www.angiodynamics.com

Address:

14 Plaza Drive, Latham, United States

N8LongShort Jun. 5 at 1:57 PM

$ANGO $XBI $IHI $IWM

0 · Reply

N8LongShort Jun. 5 at 1:44 PM

$ANGO ive got 13k shares will sell at 100

0 · Reply

SuperCoach Jun. 4 at 1:28 PM

$ANGO This baby never does a “gap and go.” I’d love to see that this morning.

0 · Reply

N8LongShort May. 29 at 2:39 PM

$ANGO https://www.businesswire.com/news/home/20260528366815/en/AngioDynamics-Expands-Patient-Access-to-NanoKnife-IRE-for-Prostate-and-Liver-Cancer-as-Medicare-Coverage-Framework-Takes-Effect $XBI $IHI $IWM

0 · Reply

Estimize May. 28 at 10:09 PM

Wall St is expecting -0.09 EPS for $ANGO Q4 [Reporting 07/21 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c

0 · Reply

N8LongShort May. 27 at 4:00 PM

$ANGO more DD

0 · Reply

N8LongShort May. 27 at 1:57 PM

$ANGO https://time.com/collections/best-inventions-2025/7318433/angiodynamics-nanoknife/ 97% tute owned, when retail comes its going to 100 $XBI $IHI $IWM

0 · Reply

N8LongShort May. 27 at 1:52 PM

$ANGO waiting on new ceo, 2 former medtronic bigwigs on board

0 · Reply

NotSure117 May. 27 at 12:27 AM

$ANGO holding 1000 shares in one of the IRAs for the big boom, Paytience 🙏🏼💎

0 · Reply

N8LongShort May. 22 at 8:15 PM

$ANGO this will get purchased by jnj in next 3 years

0 · Reply

AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect

May 27, 2026, 8:30 AM EDT - 10 days ago

AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

2026-05-26T14:33:56.000Z - 11 days ago

3 Unknown Small-Cap Stocks with ‘Strong Buy’ Ratings and Up to 70% Upside in 2026

KRNT SEPN

2026-05-13T14:48:34.000Z - 24 days ago

AngioDynamics announces two-year PRESERVE trial data

May 13, 2026, 9:00 AM EDT - 24 days ago

AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer

Apr 14, 2026, 8:45 AM EDT - 7 weeks ago

AngioDynamics Transcript: 25th Annual Needham Virtual Healthcare Conference

2026-04-06T13:46:47.000Z - 2 months ago

AngioDynamics initiated with a Buy at Freedom Broker

2026-04-06T11:01:04.000Z - 2 months ago

AngioDynamics price target lowered to $16 from $18 at Canaccord

Apr 2, 2026, 8:00 AM EDT - 2 months ago

AngioDynamics Earnings Call Transcript: Q3 2026

Apr 2, 2026, 8:00 AM EDT - 2 months ago

AngioDynamics Quarterly report: Q3 2026

Apr 2, 2026, 8:00 AM EDT - 2 months ago

AngioDynamics Earnings release: Q3 2026

Apr 2, 2026, 8:00 AM EDT - 2 months ago

AngioDynamics Slides: Q3 2026

2026-04-02T10:07:11.000Z - 2 months ago

AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)

2026-04-02T10:05:11.000Z - 2 months ago

AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)

Apr 2, 2026, 6:00 AM EDT - 2 months ago

AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability

Mar 31, 2026, 8:00 AM EDT - 2 months ago

AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 19, 2026, 8:00 AM EDT - 2 months ago

AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026

Mar 9, 2026, 1:40 PM EDT - 3 months ago

AngioDynamics Transcript: Leerink Global Healthcare Conference 2026

Feb 23, 2026, 4:30 PM EST - 3 months ago

AngioDynamics to Present at the Leerink Partners Global Healthcare Conference

Feb 19, 2026, 8:30 AM EST - 3 months ago

AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform

Feb 5, 2026, 8:00 AM EST - 4 months ago

AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care

Feb 3, 2026, 8:00 AM EST - 4 months ago

AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance

Jan 14, 2026, 6:00 PM EST - 5 months ago

AngioDynamics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:00 PM EST - 5 months ago

AngioDynamics Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 8:00 AM EST - 5 months ago

AngioDynamics Earnings Call Transcript: Q2 2026

Jan 6, 2026, 8:00 AM EST - 5 months ago

AngioDynamics Quarterly report: Q2 2026

Jan 6, 2026, 8:00 AM EST - 5 months ago

AngioDynamics Earnings release: Q2 2026

Jan 6, 2026, 8:00 AM EST - 5 months ago

AngioDynamics Slides: Q2 2026

2026-01-06T11:26:29.000Z - 5 months ago

AngioDynamics says still expects to be cash flow positive for FY26

2026-01-06T11:06:04.000Z - 5 months ago

AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)

2026-01-06T11:05:46.000Z - 5 months ago

AngioDynamics backs FY26 adjusted EPS view (33c)-(23c), consensus (33c)

2026-01-06T11:05:18.000Z - 5 months ago

AngioDynamics says Jim Clemmer to retire during FY27 as CEO

Jan 6, 2026, 6:00 AM EST - 5 months ago

AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

Dec 23, 2025, 8:00 AM EST - 5 months ago

AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026

Dec 22, 2025, 8:00 AM EST - 5 months ago

AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 10, 2025, 8:00 AM EST - 7 months ago

AngioDynamics Transcript: UBS Global Healthcare Conference 2025

Oct 27, 2025, 4:30 PM EDT - 7 months ago

AngioDynamics to Participate in the UBS Global Healthcare Conference

2025-10-17T15:45:12.000Z - 8 months ago

AngioDynamics management to meet with Lake Street

Oct 13, 2025, 8:30 AM EDT - 8 months ago

AngioDynamics' NanoKnife® System Named to TIME's 2025 Best Inventions List

2025-10-03T12:01:47.000Z - 8 months ago

AngioDynamics price target raised to $18 from $17 at Canaccord

Oct 2, 2025, 8:00 AM EDT - 8 months ago

AngioDynamics Earnings Call Transcript: Q1 2026

Oct 2, 2025, 8:00 AM EDT - 8 months ago

AngioDynamics Quarterly report: Q1 2026

Oct 2, 2025, 8:00 AM EDT - 8 months ago

AngioDynamics Earnings release: Q1 2026

Oct 2, 2025, 8:00 AM EDT - 8 months ago

AngioDynamics Slides: Q1 2026

Oct 2, 2025, 6:00 AM EDT - 8 months ago

AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum

Sep 25, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics Proxy statement: Proxy Filing

Sep 25, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics Proxy statement: Proxy Filing

Sep 18, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025

Aug 12, 2025, 9:00 AM EDT - 10 months ago

AngioDynamics Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 6, 2025, 4:30 PM EDT - 10 months ago

AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 28, 2025, 8:30 AM EDT - 11 months ago

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

Jul 23, 2025, 8:30 AM EDT - 11 months ago

AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology

Jul 15, 2025, 8:00 AM EDT - 11 months ago

AngioDynamics Earnings Call Transcript: Q4 2025

Jul 15, 2025, 8:00 AM EDT - 11 months ago

AngioDynamics Annual report: Q4 2025

Jul 15, 2025, 8:00 AM EDT - 11 months ago

AngioDynamics Earnings release: Q4 2025

Jul 15, 2025, 8:00 AM EDT - 11 months ago

AngioDynamics Slides: Q4 2025

Jul 15, 2025, 6:30 AM EDT - 11 months ago

AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth

Jul 7, 2025, 8:00 AM EDT - 11 months ago

AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025

Jun 23, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism

Apr 2, 2025, 9:00 AM EDT - 1 year ago

AngioDynamics Transcript: Investor Update

Apr 2, 2025, 9:00 AM EDT - 1 year ago

AngioDynamics Slides: Investor Update

Apr 2, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings Call Transcript: Q3 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Quarterly report: Q3 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings release: Q3 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Slides: Q3 2025

Apr 2, 2025, 6:30 AM EDT - 1 year ago

AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results

Mar 31, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics to Host Virtual Cardiovascular Investor Event

Mar 19, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event

Mar 10, 2025, 4:30 PM EDT - 1 year ago

AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference

Jan 30, 2025, 7:30 AM EST - 1 year ago

AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia

Jan 16, 2025, 10:30 AM EST - 1 year ago

AngioDynamics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 16, 2025, 10:30 AM EST - 1 year ago

AngioDynamics Slides: FY 2025

Jan 13, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI

Jan 8, 2025, 9:30 AM EST - 1 year ago

AngioDynamics Transcript: Investor Update

Jan 8, 2025, 9:30 AM EST - 1 year ago

AngioDynamics Slides: Investor Update

Jan 8, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Earnings Call Transcript: Q2 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Quarterly report: Q2 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Earnings release: Q2 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Slides: Q2 2025

Jan 8, 2025, 6:30 AM EST - 1 year ago

AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results

Jan 6, 2025, 9:26 AM EST - 1 year ago

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

Jan 6, 2025, 9:25 AM EST - 1 year ago

AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System

Dec 19, 2024, 5:00 PM EST - 1 year ago

AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

Dec 9, 2024, 6:00 AM EST - 1 year ago

AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation

Oct 23, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

Oct 21, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Announces American Medical Association's CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver

Oct 3, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings Call Transcript: Q1 2025

Oct 3, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Quarterly report: Q1 2025

Oct 3, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings release: Q1 2025

Oct 3, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Slides: Q1 2025

Oct 3, 2024, 6:30 AM EDT - 1 year ago

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

Sep 26, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Proxy statement: Proxy Filing

Sep 26, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Proxy statement: Proxy Filing

Sep 19, 2024, 4:40 PM EDT - 1 year ago

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

Sep 19, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024

Sep 3, 2024, 8:30 AM EDT - 1 year ago

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

Aug 13, 2024, 10:00 AM EDT - 1 year ago

AngioDynamics Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 13, 2024, 10:00 AM EDT - 1 year ago

AngioDynamics Slides: FY 2024

Jul 29, 2024, 4:15 PM EDT - 2 years ago

AngioDynamics to Participate in Upcoming Investor Conferences

Jul 16, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Earnings Call Transcript: Q4 2024

Jul 16, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Annual report: Q4 2024

Jul 16, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Earnings release: Q4 2024

Jul 16, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Slides: Q4 2024

Jul 16, 2024, 6:30 AM EDT - 2 years ago

AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results

Jul 8, 2024, 4:30 PM EDT - 2 years ago

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

May 21, 2024, 5:30 PM EDT - 2 years ago

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System

May 6, 2024, 4:45 PM EDT - 2 years ago

AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions

Apr 4, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Earnings Call Transcript: Q3 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Quarterly report: Q3 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Earnings release: Q3 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Slides: Q3 2024

Apr 4, 2024, 7:00 AM EDT - 2 years ago

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

Apr 4, 2024, 6:45 AM EDT - 2 years ago

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE

Apr 1, 2024, 5:26 PM EDT - 2 years ago

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

Mar 19, 2024, 4:01 PM EDT - 2 years ago

AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024

Mar 12, 2024, 12:40 PM EDT - 2 years ago

AngioDynamics Transcript: Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Mar 6, 2024, 4:01 PM EST - 2 years ago

AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference

N8LongShort Jun. 5 at 1:57 PM

$ANGO $XBI $IHI $IWM

0 · Reply

N8LongShort Jun. 5 at 1:44 PM

$ANGO ive got 13k shares will sell at 100

0 · Reply

SuperCoach Jun. 4 at 1:28 PM

$ANGO This baby never does a “gap and go.” I’d love to see that this morning.

0 · Reply

N8LongShort May. 29 at 2:39 PM

0 · Reply

Estimize May. 28 at 10:09 PM

Wall St is expecting -0.09 EPS for $ANGO Q4 [Reporting 07/21 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c

0 · Reply

N8LongShort May. 27 at 4:00 PM

$ANGO more DD

0 · Reply

N8LongShort May. 27 at 1:57 PM

$ANGO https://time.com/collections/best-inventions-2025/7318433/angiodynamics-nanoknife/ 97% tute owned, when retail comes its going to 100 $XBI $IHI $IWM

0 · Reply

N8LongShort May. 27 at 1:52 PM

$ANGO waiting on new ceo, 2 former medtronic bigwigs on board

0 · Reply

NotSure117 May. 27 at 12:27 AM

$ANGO holding 1000 shares in one of the IRAs for the big boom, Paytience 🙏🏼💎

0 · Reply

N8LongShort May. 22 at 8:15 PM

$ANGO this will get purchased by jnj in next 3 years

0 · Reply

N8LongShort May. 22 at 1:36 PM

$ANGO love a quite stock twits board

0 · Reply

N8LongShort May. 20 at 3:00 PM

$ANGO not sure why nanoknife isnt on cathys radar $ARKK

0 · Reply

N8LongShort May. 19 at 7:11 PM

$ANGO $IWM $XBI

0 · Reply

N8LongShort May. 19 at 6:10 PM

$ANGO wow Steve Cohen owns 7% of shares $IWM $XBI 90% tute owned improving fundamentals follow the rich guys

0 · Reply

N8LongShort May. 19 at 1:46 PM

$ANGO this is a sleeper 97% inst owned with consolidating moving averages and increasing top line in multiple segments$XBI $IWM

0 · Reply

Estimize May. 11 at 1:06 PM

Wall St is expecting -0.09 EPS for $ANGO Q4 [Reporting 07/21 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c

0 · Reply

BillionerOfKing May. 4 at 7:27 PM

$ANGO Current Stock Price: $10.98 Contracts to trade: $10.0 ANGO May 15 2026 Call Entry: $0.90 Exit: $1.45 ROI: 61% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

N8LongShort Apr. 30 at 6:28 PM

$ANGO easy trade to 20

0 · Reply

N8LongShort Apr. 30 at 6:24 PM

$ANGO in

0 · Reply

SuperGreenToday Apr. 16 at 1:00 AM

$ANGO Share Price: $10.35 Contract Selected: Oct 16, 2026 $10 Calls Buy Zone: $1.32 – $1.63 Target Zone: $2.48 – $3.03 Potential Upside: 78% ROI Time to Expiration: 183 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Knot2 Apr. 15 at 2:06 PM

$ANGO something good is afoot

0 · Reply

SolarWind Apr. 7 at 3:34 PM

$ANGO created a substantial position today.

0 · Reply

Market Cap	497.07M
Revenue (ttm)	292.50M
Net Income (ttm)	-33.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-11.62%
Debt to Equity Ratio	0.00

Volume	385,700
Avg Vol	402,534
Day's Range	N/A - N/A
Shares Out	41.32M
Stochastic %K	87%
Beta	0.38
Analysts	Strong Sell
Price Target	$18.00